1201574-92-6

Basic information

• Product Name: (3R,4S)-1-benzyl-4-phenylpyrrolidine-3-carboxylic acid
• Synonyms: (3R,4S)-1-benzyl-4-phenylpyrrolidine-3-carboxylic acid
• CAS NO: 1201574-92-6
• Molecular Weight: 281.354
• Mol File: 1201574-92-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (3R,4S)-1-benzyl-4-phenylpyrrolidine-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,4S)-1-benzyl-4-phenylpyrrolidine-3-carboxylic acid(1201574-92-6)
• EPA Substance Registry System: (3R,4S)-1-benzyl-4-phenylpyrrolidine-3-carboxylic acid(1201574-92-6)

Safety Data

• Hazardous Substances Data: 1201574-92-6(Hazardous Substances Data)

Upstream product

• 1201574-98-2 3-{benzyl[(2R)-2-chloro-2-phenylethyl]amino}propanenitrile 
• 706-03-6 3-(benzylamino)propionitrile 
• 20780-53-4 (R)-Styrene oxide 
• 438492-33-2 (3R,4S)-methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate 

Downstream Products

• 221141-87-3 [(3R,4S)-1-benzyl-4-phenylpyrrolidin-3-yl]methanol 

Relevant articles and documents

NOVEL METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUND

[Object] A novel method for producing an optically active pyrrolidine compound, which is useful as a production intermediate of a pharmaceutical, and a production intermediate thereof, is provided. [Means for Solution] According to the production method o

Tricyclic indanyls as integrin inhibitors

The present invention is directed to substituted indanyl compounds of Formula (I): Useful for treating integrin-mediated disorders such as, but not limited to unstable angina, thromboemboic disorders, osteoporosis, growth and metastasis of malignant tumors, diabetic retinopathy, arthritis, viral disease and surgical adhesions.